22 May 2013
Keywords: roche, closes, gw, flu, drug, race, said
Article | 18 March 1999
Roche has said that it hopes to file for approval of its neuraminidaseinhibitor GS4104, licensed from Gilead Sciences, in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.